Weave's AI-Powered Growth Surges with 17% Revenue Increase

📊 Key Data
  • 17% Revenue Increase: Weave reported a 17% year-over-year revenue increase for Q4 and full-year 2025, with total revenue reaching $239.0 million annually.
  • Non-GAAP Operating Income: Full-year non-GAAP operating income surged to $4.1 million, a five-fold increase from 2024.
  • Customer Growth: Added 4,628 net new customer locations in 2025, bringing the total to nearly 40,000.
🎯 Expert Consensus

Experts would likely conclude that Weave's AI-powered platform is driving significant operational efficiency and financial improvement in healthcare practices, positioning the company for sustained growth in the competitive patient engagement market.

about 2 months ago
Weave's AI-Powered Growth Surges with 17% Revenue Increase

Weave's AI-Powered Growth Surges with 17% Revenue Increase

LEHI, Utah – February 19, 2026 – Weave Communications, Inc. (NYSE: WEAV) today announced robust financial results for the fourth quarter and full fiscal year 2025, signaling strong momentum for its AI-powered patient engagement platform. The company reported a 17% year-over-year revenue increase for both periods, driven by customer growth and strategic initiatives aimed at solidifying its role in the modern healthcare practice.

Total revenue for the fourth quarter reached $63.4 million, while full-year revenue hit $239.0 million. The growth was accompanied by what the company described as record gross margins and operating income. The results underscore Weave's strategy of transforming the administrative operations of small and medium-sized healthcare offices.

“Weave delivered another strong quarter in Q4, with 17% year-over-year revenue growth, accompanied by record gross margins and operating income,” said Brett White, CEO of Weave, in the company's press release. “As our agentic workflows expand, Weave evolves from a product practices use to an always-on teammate they rely on. We reduce administrative burden, improve conversion and collections, and free staff to focus on high-value patient care.”

A Clearer Path to Profitability

Beyond the top-line growth, Weave demonstrated significant progress in its financial discipline and operational efficiency. The company's GAAP loss from operations for the fourth quarter narrowed substantially to $2.2 million, a stark improvement from the $7.4 million loss reported in the same quarter of 2024. For the full year, the GAAP operating loss also saw a slight improvement to $30.6 million from $31.4 million the previous year.

On a non-GAAP basis, which excludes items like stock-based compensation, the picture is even brighter. Weave posted a non-GAAP income from operations of $2.3 million in Q4 2025. More impressively, its full-year non-GAAP operating income surged to $4.1 million, a more than five-fold increase from the $0.8 million reported in 2024. This indicates that the core business operations are becoming increasingly profitable.

Positive cash flow further strengthens the company's financial position. For the full year 2025, Weave generated $12.9 million in free cash flow, up from $10.4 million in 2024. While the company remains unprofitable on a GAAP basis, and analysts note that a full break-even point may still be a few years away, the consistent reduction in losses and growth in non-GAAP income and free cash flow signal a sustainable financial trajectory and effective cost management.

Strategic Alliances Fuel Market Expansion

Weave's growth is not solely organic; it is being significantly amplified by strategic partnerships that expand its reach and validate its platform. The company added 4,628 net new customer locations in 2025, bringing its total to nearly 40,000, a testament to the success of its market strategy.

Two recent announcements are particularly pivotal. First, a new partnership with CareCredit, a major patient financing solution from Synchrony Financial, integrates flexible payment options directly into Weave's workflows. This move is designed to reduce payment friction, improve treatment plan acceptance rates, and enhance the patient experience by making care more affordable. It firmly embeds Weave within the critical financial operations of a healthcare practice.

Second, Weave secured a landmark endorsement from the American Dental Association (ADA) as its preferred patient engagement solution. This endorsement provides Weave with exclusive co-marketing opportunities to the ADA's vast network of 160,000 members. For a company with a heavy concentration in the dental sector, this validation is a powerful competitive advantage, building trust and creating a direct channel for customer acquisition.

Redefining the Front Office with AI

At the heart of Weave's value proposition is its mission to create the 'intelligent front office.' The company is moving beyond simple communication tools by deploying what CEO Brett White calls 'agentic workflows'—AI-powered systems that act as an 'always-on teammate' for administrative staff.

A prime example is the recently announced Weave Insurance Eligibility feature. This tool leverages Robotic Process Automation (RPA) to transform the historically tedious and time-consuming process of verifying patient insurance. Instead of staff spending hours on phone calls or navigating dozens of different payer websites, Weave's system automates the process, pulling comprehensive coverage details directly from payer portals. This not only boosts practice efficiency but also improves financial health by providing clarity on payment responsibility before treatment begins.

This is part of a broader push into AI that includes a response assistant for managing online reviews and call intelligence features that help automate appointment scheduling. By embedding AI directly into daily tasks, Weave aims to deliver tangible returns on investment for practices struggling with administrative overload.

Navigating a Crowded and Growing Market

Weave operates within the rapidly expanding patient engagement solutions market, which is projected to grow at a compound annual growth rate of nearly 20% to over $34 billion by 2032. This growth is fueled by a healthcare industry-wide push for digitalization and patient-centered care. However, this lucrative market is also highly fragmented and competitive, featuring a range of players from startups to established companies like Luma Health, NexHealth, and Solutionreach.

Weave's all-in-one platform, which combines phone, text, payments, and scheduling, remains a key differentiator in a market where practices often have to stitch together multiple disparate solutions. However, analysts point to potential risks, including the company's heavy revenue concentration in the dental and optometry verticals. While the ADA endorsement solidifies its strength in dentistry, future growth will depend on its ability to successfully penetrate new specialty medical fields and navigate potential shifts in the healthcare landscape.

Looking ahead, Weave provided an optimistic outlook for 2026. The company projects first-quarter revenue between $64.2 million and $64.8 million and full-year revenue in the range of $273.0 million to $276.0 million. This guidance suggests continued confidence in its growth strategy and its ability to capture a larger share of the intelligent front office market.

Theme: AI & Emerging Technology Automation
Sector: AI & Machine Learning Health IT Fintech Software & SaaS
Event: Compliance Action IPO Acquisition
Product: ChatGPT
Metric: Free Cash Flow Revenue
UAID: 17201